The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136.
Northeast Bank
NBN · Nasdaq · USD · Market cap $1.2B · 211 employees
Northeast Bank provides various banking services to individual and corporate customers in Maine.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price127.28 USD at the 13 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $151.00 to $254.56, base estimate $151.00 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Northeast Bank holds its Markup at $127.28. Consolidating, no directional conviction, held for 191 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 191 days |
| Price at the screen | $127.28 |
| Valuation | 10.54 trailing · 8.42 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.64 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: bank
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: bank | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Northeast Bank does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when NBN's ethical verdict changes
Today NBN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 16% discount to our $151.00 fair value, 19.10% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 15.7% discount to the base estimate.
Third-party analyst targets: 2 covering, consensus Buy. The average target sits +14% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $151.00, with a range of $151.00 to $254.56, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsMaine bank clears the numbers but not the gate
Every time a small business in Maine needs a loan or a family opens a savings account, the transaction lands inside a regional bank like this one. The numbers look solid on paper, with revenue up 35 percent, a 43 percent profit margin and 19 percent return on equity. Forward earnings sit at just 9.1 times and the shares trade below our own fair-value mark, yet the opportunity rating stays at none.
We pass because the ethical screen blocks banks outright. That single rule overrides attractive growth, solid margins and a consensus buy rating from the two analysts who follow the name. The screen exists to keep us out of entire sectors regardless of how cheap or fast-growing any single name appears.
Valuation sits close to the analyst median target of 136 dollars while the shares remain exposed to interest-rate swings and credit cycles that can turn peak earnings into a trap. The unknown moat adds another layer of uncertainty in a crowded regional market. Analysis, not advice.
| Forward P/E | 8.4xcheap for a company growing this fast |
| Trailing P/E | 10.5xreasonably valued |
| EPS, trailing | 12.74 |
| EPS, forward | 15.95 |
| Revenue growth | +19.1%steady growth |
| Profit margin | 46.1%highly profitable on every dollar of sales |
| Return on equity | 20.0%a solid return on shareholder capital |
| Dividend yield | 0.03% |
| Beta | 0.64steadier than the market |
| Short interest, float | 0.07% |
| 52-week range | 80.75 - 142.31 |
| Market cap | $1.2B |
| Employees | 211 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeNBN trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 48%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (2 analysts) rates it none, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Earnings Growth Might Change The Case For Investing In Northeast Bank (NBN) Yahoo Finance · 11d ago
- Northeast Bank (NBN) Stock Slips Despite Strong Q1 Earnings Yahoo Finance · 18d ago
- Northeast Bancorp Q1 Earnings Call Highlights Yahoo Finance · 20d ago
- Northeast Bancorp: Fiscal Q1 Earnings Snapshot Yahoo Finance · 20d ago
- Northeast Bank Reports First Quarter Results and Declares Dividend Yahoo Finance · 20d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $123.33 | +2.7% | $0.01 | $1,027 | +2.7% |
| 2 months | $123.89 | +2.2% | $0.01 | $1,022 | +2.2% |
| 3 months | $108.79 | +16.4% | $0.01 | $1,164 | +16.4% |
| 6 months | $99.30 | +27.5% | $0.02 | $1,275 | +27.5% |
| 1 year | $85.67 | +47.8% | $0.04 | $1,478 | +47.8% |
| 2 years | $55.72 | +127.2% | $0.08 | $2,274 | +127.4% |
| 3 years | $41.46 | +205.4% | $0.12 | $3,056 | +205.6% |
| 5 years | $29.82 | +324.6% | $0.20 | $4,253 | +325.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever NBN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.